Literature DB >> 2998702

Age-related changes of calpain II and alpha-crystallin in the lens of hereditary cataract (Nakano) mouse.

H Yoshida, T Murachi, I Tsukahara.   

Abstract

The age-related changes of calpain II (high-Ca2+-requiring form of Ca2+-dependent cysteine proteinase; EC 3.4.22.17) and alpha-crystallin in the lens of hereditary cataract (Nakano; cac/cac) mouse were studied. Before the onset of the cataract formation, i.e., at the end of the 2nd week after birth, the calpain activity in Nakano mice was as high as that in the control ICR mice, but it decreased rapidly as the cataract progressed to completion during the 4th and the 12th week. Marked degradation of lens proteins ensued between the 2nd and the 4th weeks, and one of these proteins was identified, using monospecific antibodies, as B chain of alpha-crystallin. A chain of alpha-crystallin was not degraded in vivo, in contrast to its known susceptibility to calpain in vitro. The present data suggest that in Nakano mice, calpain may be involved in the onset or early stage of the cataract formation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998702     DOI: 10.3109/02713689509000005

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  2 in total

1.  Regulatory effect of chrysin on expression of lenticular calcium transporters, calpains, and apoptotic-cascade components in selenite-induced cataract.

Authors:  Mahalingam Sundararajan; Philip A Thomas; P Archana Teresa; Muniyandi Anbukkarasi; Pitchairaj Geraldine
Journal:  Mol Vis       Date:  2016-04-30       Impact factor: 2.367

2.  Reduction of oxidative-nitrosative stress underlies anticataract effect of topically applied tocotrienol in streptozotocin-induced diabetic rats.

Authors:  Nurul Alimah Abdul Nasir; Renu Agarwal; Siti Hamimah Sheikh Abdul Kadir; Sushil Vasudevan; Minaketan Tripathy; Igor Iezhitsa; Aqil Mohammad Daher; Mohd Ikraam Ibrahim; Nafeeza Mohd Ismail
Journal:  PLoS One       Date:  2017-03-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.